We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$7.23M
Cap. Flow
+$41.2M
Cap. Flow %
4.08%
Top 10 Hldgs %
71.39%
Holding
55
New
11
Increased
7
Reduced
25
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 22.55%
2 Healthcare 15.88%
3 Communication Services 13.42%
4 Consumer Staples 9.62%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$78.2B
$134M 13.22%
172,787
-3,981
-2% -$3.05M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.62T
$110M 10.86%
381,490
-34,473
-8% -$10.8M
IBKR icon
3
Interactive Brokers
IBKR
$39.5B
$86M 8.51%
1,281,731
-204,563
-14% -$14.6M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.12T
$74.3M 7.36%
155,063
-7,264
-4% -$3.57M
AMZN icon
5
Amazon
AMZN
$2.99T
$59.5M 5.89%
285,739
+8,098
+3% +$1.78M
PM icon
6
Philip Morris
PM
$291B
$56.4M 5.58%
341,098
-57,458
-14% -$9.98M
REGN icon
7
CALL
Regeneron Pharmaceuticals
REGN
$78.2B
$53M 5.24%
68,600
+9,300
+16% +$7.12M
CTVA icon
8
Corteva
CTVA
$50.7B
$42.1M 4.17%
502,790
-66,243
-12% -$4.99M
COF icon
9
Capital One
COF
$134B
$34.2M 3.38%
187,369
+11,829
+7% +$2.47M
FCNCA icon
10
First Citizens BancShares
FCNCA
$25.3B
$31.1M 3.08%
16,492
-580
-3% -$1.16M
DIS icon
11
Walt Disney
DIS
$170B
$17.9M 1.77%
+185,677
New +$19.6M
TBBB icon
12
BBB Foods
TBBB
$5.17B
$17.2M 1.71%
487,550
+93,392
+24% +$3.27M
NKTR icon
13
CALL
Nektar Therapeutics
NKTR
$2.38B
$14.6M 1.44%
+202,500
New +$11.5M
NKTR icon
14
Nektar Therapeutics
NKTR
$2.38B
$14.3M 1.41%
+198,256
New +$11.3M
HLF icon
15
Herbalife
HLF
$1.33B
$13.8M 1.37%
939,926
-180,249
-16% -$2.94M
GHC icon
16
Graham Holdings Company
GHC
$5.14B
$13.5M 1.34%
12,785
-570
-4% -$628K
BF.A icon
17
CALL
Brown-Forman Class A
BF.A
$12.9B
$13.1M 1.29%
+493,902
New +$13.4M
ALNY icon
18
Alnylam Pharmaceuticals
ALNY
$29.5B
$12.3M 1.22%
37,245
-1,619
-4% -$551K
IWO icon
19
iShares Russell 2000 Growth ETF
IWO
$15B
$11.8M 1.17%
+37,542
New +$12.5M
IBB icon
20
iShares Biotechnology ETF
IBB
$9.39B
$11.7M 1.16%
69,265
-3,085
-4% -$528K
SQM icon
21
Sociedad Química y Minera de Chile
SQM
$19.6B
$9.91M 0.98%
122,419
-41,038
-25% -$3.12M
AUR icon
22
Aurora
AUR
$14.2B
$9.55M 0.95%
+2,318,748
New +$10.3M
NEM icon
23
Newmont
NEM
$103B
$8.16M 0.81%
75,408
-2,448
-3% -$282K
PINS icon
24
Pinterest
PINS
$14.3B
$7.9M 0.78%
430,950
-81,246
-16% -$1.7M
GLBE icon
25
Global E Online
GLBE
$6.75B
$6.57M 0.65%
+213,102
New +$7.5M

Similar funds

Bronte Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Bronte Capital Management held 55 positions worth $1.01B, up 0.72% from $1B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bronte Capital Management deployed $41.2M of net new capital in Q1 2026, opening 11 new positions and adding to 7 existing holdings. Its largest new stake was Walt Disney: 185,677 shares worth $17.9M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Interactive Brokers, an estimated $14.6M trimmed.

  • Bronte Capital Management's largest Q1 2026 buy was Walt Disney: 185,677 shares worth $17.9M.
  • Bronte Capital Management added most to BBB Foods in Q1 2026, an estimated $3.27M increase.
  • Bronte Capital Management's biggest Q1 2026 reduction was Interactive Brokers, cutting an estimated $14.6M.
  • Bronte Capital Management fully exited Fair Isaac in Q1 2026, selling an estimated $2.65M.
  • Bronte Capital Management's ten largest holdings make up 71% of its $1.01B portfolio in Q1 2026.
  • Bronte Capital Management opened 11 new positions and closed 1 in Q1 2026.
  • Bronte Capital Management's portfolio value rose 0.72% quarter-over-quarter to $1.01B.

Based on Bronte Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.